10
votes
Size of McKinsey consulting firm opioid settlement increased by $230 million
Link information
This data is scraped automatically and may be incorrect.
- Title
- Consulting firm McKinsey to pay $230 million in latest US opioid settlements
- Authors
- Nate Raymond
- Published
- Sep 27 2023
- Word count
- 376 words
Here is one noteworthy document about creating brand loyalty to OxyContin
https://www.industrydocuments.ucsf.edu/opioids/docs/#id=zxwf0257
Here is an archive of the McKinsey documents related to their business with pharmaceutical companies and opiate drugs. https://www.industrydocuments.ucsf.edu/opioids/collections/mckinsey-documents/
Shoutout to the NakedCapitalism finance blog for highlighting the existence of the archive.
The link to their discussion is here.
https://www.nakedcapitalism.com/2023/09/consulting-ethics-mckinsey-pays-additional-230-million-opioid-settlement-bringing-total-to-870-million.html
Edit NakedCapitalism is a blog I discovered in 2008. They did reporting re the financial crisis that was useful and interesting. As the blog has developed over time, I sometimes disagree with their editorial stance, but they continue to find and publish useful and interesting information
I've been seeing a lot of McKinsey and Co. articles here lately. Are they in serious trouble or something, or is this just some frequency illusion? There are two articles up now, plus The Nation article from a week or so ago.
The second article is from 2022, but talks about pattern and practice of how this business behaves. I wonder if my current news article triggered it?
The opioid settlement is a big deal. There have been a lot of deaths, directly caused by the pharmaceutical companies and their enablers like McKinsey. Also, McKinsey and similar companies typically advise squeezing labor to extract profit and labor is trending more powerful and popular than ten years ago. I would say McKinsey has lost a lot of their reputation, much like the tobacco companies did.